Add to ORKGIntroduction: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) admission remains a severe medical condition, presenting ICU mortality rates reaching 30%. The aim of this study was to assess the value of different patterns of C-reactive protein (CRP)-ratio response to antibiotic therapy in patients with severe CAP requiring ICU admission as an early maker of outcome. Methods: In total, 191 patients with severe CAP were prospectively included and CRP was sampled every othe
Finding relevant biomarkers as a potential predictor of severity for patients hospitalized with comm...
Background: Because the cost of inpatient care for pneumonia is up to 25 times greater than that of ...
BACKGROUND C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for co...
Introduction: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) admission remai...
AbstractPrevious studies on the usefulness of C-reactive protein (CRP) in patients with community-ac...
Publisher Copyright: © 2015 Sarmet Cunha Farah Rabello et al.Intr Pneumonia is the most frequent typ...
Introduction: Community-acquired pneumonia (CAP) presents high mortality rates and high healthcare c...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
C-Reactive protein (CRP) is widely used as a marker of infection, but there is insufficient evidence...
Despite the introduction of new inflammatory markers, C-reactive protein (CRP) remains commonly used...
AbstractBackgroundBecause the cost of inpatient care for pneumonia is up to 25 times greater than th...
Community-acquired pneumonia (CAP) is a major clinical problem in terms of morbidity, mortality, and...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
protein measurements in follow-up of severe community-acquired pneumonia A.H.W. Bruns*, J.J. Oosterh...
PURPOSE: To identify risk factors associated with mortality in patients with severe community-acquir...
Finding relevant biomarkers as a potential predictor of severity for patients hospitalized with comm...
Background: Because the cost of inpatient care for pneumonia is up to 25 times greater than that of ...
BACKGROUND C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for co...
Introduction: Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) admission remai...
AbstractPrevious studies on the usefulness of C-reactive protein (CRP) in patients with community-ac...
Publisher Copyright: © 2015 Sarmet Cunha Farah Rabello et al.Intr Pneumonia is the most frequent typ...
Introduction: Community-acquired pneumonia (CAP) presents high mortality rates and high healthcare c...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
C-Reactive protein (CRP) is widely used as a marker of infection, but there is insufficient evidence...
Despite the introduction of new inflammatory markers, C-reactive protein (CRP) remains commonly used...
AbstractBackgroundBecause the cost of inpatient care for pneumonia is up to 25 times greater than th...
Community-acquired pneumonia (CAP) is a major clinical problem in terms of morbidity, mortality, and...
Background/aim: There has been growing interest in the use of serum procalcitonin (PCT) and C-reacti...
protein measurements in follow-up of severe community-acquired pneumonia A.H.W. Bruns*, J.J. Oosterh...
PURPOSE: To identify risk factors associated with mortality in patients with severe community-acquir...
Finding relevant biomarkers as a potential predictor of severity for patients hospitalized with comm...
Background: Because the cost of inpatient care for pneumonia is up to 25 times greater than that of ...
BACKGROUND C-reactive protein (CRP) is increasingly being included in the diagnostic work-up for co...